Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedMay 10, 2017Rabeprazole Sodium Delayed Release TabletsFailed Dissolution SpecificationsAmneal Pharmaceuticals LLC · D-0693-2017Class IIITerminatedMay 10, 2017Aripiprazole TabletsSuperpotent Drug; out of specification results for assay (manufacturer)The Harvard Drug Group · D-0692-2017Class IOngoingMay 10, 2017EpiPen Jr. 2-PakDefective Delivery System; reports of the device failing to activate which could result in a patient not receiving medicationMeridian Medical Technologies a Pfizer Company · D-0691-2017Class IOngoingMay 10, 2017EpiPen 2-PakDefective Delivery System; reports of the device failing to activate which could result in a patient not receiving medicationMeridian Medical Technologies a Pfizer Company · D-0690-2017Class IITerminatedMay 10, 2017Fluconazole TabletsFailed Dissolution SpecificationsThe Harvard Drug Group · D-0689-2017Class IITerminatedMay 10, 2017Fluconazole TabletsFailed Dissolution SpecificationsThe Harvard Drug Group · D-0688-2017Class IITerminatedMay 3, 2017Phenylephrine 2.5%Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.Isomeric Pharmacy Solution, LLC · D-0687-2017Class IITerminatedMay 3, 2017Testosterone Cypionate 200 mg/mLLack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.Isomeric Pharmacy Solution, LLC · D-0686-2017Class IITerminatedMay 3, 2017Cyanocobalamin 1 mg/mL/ Methionine 25 mg/mL/ Inositol 50 mg/mL/ Choline 50 mg/mLLack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.Isomeric Pharmacy Solution, LLC · D-0685-2017Class IITerminatedMay 3, 2017Triamcinolone Diacetate 40 mg/mLLack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.Isomeric Pharmacy Solution, LLC · D-0684-2017Class IITerminatedMay 3, 2017Triamcinolone Acetonide 40 mg/mLLack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.Isomeric Pharmacy Solution, LLC · D-0683-2017Class IITerminatedMay 3, 2017Methylprednisolone Acetate 80 mg/mLLack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.Isomeric Pharmacy Solution, LLC · D-0682-2017Class IITerminatedMay 3, 2017Methylprednisolone Acetate 40 mg/mLLack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.Isomeric Pharmacy Solution, LLC · D-0681-2017Class IIITerminatedMay 3, 2017Donepezil HCl tabletsSupotent: Out of Specification result for assay test during routine stability testing.Mckesson Packaging Services · D-0680-2017Class IIITerminatedMay 3, 2017Pilocarpine Hydrochloride Ophthalmic Solution 4%Failed Impurities/Degradation Specifications.Novartis Pharmaceuticals Corp. · D-0679-2017Class IIITerminatedMay 3, 2017Isopto CarpineFailed Impurities/Degradation Specifications.Novartis Pharmaceuticals Corp. · D-0678-2017Class IITerminatedMay 3, 2017hCG Body ShaperMarketed without an Approved NDA/ANDA; FDA analysis has found the product to be tainted with human chorionic gonadotropin, rendering it an unapproved drugGary Wood · D-0677-2017Class IITerminatedApr 26, 2017Nystatin and Triamcinolone Acetonide CreamFailed Content Uniformity Specifications; out-of-specification (OOS) results 18-month stabilityTaro Pharmaceuticals U.S.A., Inc. · D-0676-2017Class IIITerminatedApr 26, 2017Dye Free Allergy Softgel Gelatin CapsuleSubpotentInnovaGel · D-0675-2017Class IIITerminatedApr 26, 2017Diphenhydramine HCl 25 mgSubpotentInnovaGel · D-0674-2017Class IIITerminatedApr 26, 2017CLENZIderm M.D. Acne Treatment SystemDiscoloration.Valeant Pharmaceuticals North America LLC · D-0673-2017Class IIITerminatedApr 26, 2017CLENZIderm M.D. Pore Therapy Salicylic Acid 2% Acne Treatment 5 fl. ozDiscoloration.Valeant Pharmaceuticals North America LLC · D-0672-2017Class IIITerminatedApr 19, 2017BuPROPion Hydrochloride Extended-release TabletsFailed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.Jubilant Cadista Pharmaceuticals, Inc. · D-0671-2017Class IIITerminatedApr 19, 2017BuPROPion Hydrochloride Extended-release TabletsFailed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.Jubilant Cadista Pharmaceuticals, Inc. · D-0670-2017Class IIITerminatedApr 19, 2017BuPROPion Hydrochloride Extended-release TabletsFailed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.Jubilant Cadista Pharmaceuticals, Inc. · D-0669-2017Class IITerminatedApr 19, 2017hydrALAZINE HYDROCHLORIDE INJECTIONTemperature Abuse: Certain pieces of these lots distributed by McKesson Medical Surgical Inc. were inadvertently stored refrigerated rather than the labeled room...Mckesson Medical Surgical · D-0668-2017Class IIITerminatedApr 19, 2017LumiganFailed Impurities/Degradation SpecificationsAllergan Sales, LLC · D-0667-2017Class IITerminatedApr 19, 2017ESTRADIOLcGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspectionMedisca, Inc. · D-0666-2017Class IITerminatedApr 19, 2017ESTRADIOLcGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspectionMedisca, Inc. · D-0665-2017Class IITerminatedApr 19, 2017ESTRONE, USP BulkcGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspectionMedisca, Inc. · D-0664-2017Class IITerminatedApr 19, 2017ESTRIOL, USPcGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspectionMedisca, Inc. · D-0663-2017Class IIOngoingApr 19, 2017Double Hyaluronic 1000Microbial Contamination of Non-Sterile Products: odor complaint of product due to microbial contamination.Signature Club A Ltd · D-0662-2017Class IITerminatedApr 19, 2017LATANOPROST OPHTHALMIC SOLUTIONLack of assurance of sterility: product was found to be empty, under-filled, or leaking.Akorn, Inc. · D-0661-2017Class IITerminatedApr 19, 2017Levonorgestrel Non-MicronizedcGMP Deviations; lack of quality assurance.Qinhuangdao Zizhu Pharmaceutical, Co. · D-0660-2017Class IITerminatedApr 19, 2017Ethinyl Estradiol MicronizedcGMP Deviations; lack of quality assurance.Qinhuangdao Zizhu Pharmaceutical, Co. · D-0659-2017Class IITerminatedApr 19, 2017Testosterone MicronizedcGMP Deviations; lack of quality assurance.Qinhuangdao Zizhu Pharmaceutical, Co. · D-0658-2017Class IITerminatedApr 19, 2017Estrone MicronizedcGMP Deviations; lack of quality assurance.Qinhuangdao Zizhu Pharmaceutical, Co. · D-0657-2017Class IITerminatedApr 19, 2017Estriol MicronizedcGMP Deviations; lack of quality assurance.Qinhuangdao Zizhu Pharmaceutical, Co. · D-0656-2017Class IITerminatedApr 19, 2017Estradiol Non-MicronizedcGMP Deviations; lack of quality assurance.Qinhuangdao Zizhu Pharmaceutical, Co. · D-0655-2017Class IITerminatedApr 19, 2017Estradiol Micronized BulkcGMP Deviations; lack of quality assurance.Qinhuangdao Zizhu Pharmaceutical, Co. · D-0654-2017

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.